Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$219,103,450
+$28,858,208 QoQ
Shares Held
870,702
-0.5% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#145
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $966,440,001 across 15 Drug Manufacturers - General names. ABBV ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,028,187 | $261,128,650 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
870,702 | $219,103,450 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,365,877 | $175,515,193 | |
| 4 | LLY |
ELI LILLY & Co
|
121,140 | $145,298,959 | |
| 5 | AMGN |
Amgen Inc
|
118,830 | $43,030,717 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
252,085 | $31,848,418 | |
| 7 | NVS |
Novartis AG
|
186,086 | $29,163,396 | |
| 8 | SNY |
Sanofi
|
469,285 | $20,019,697 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,103,450 | 870,702 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $190,245,242 | 874,731 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $199,915,724 | 874,943 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $204,372,253 | 882,665 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $161,238,440 | 868,648 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $175,714,575 | 838,653 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $149,385,280 | 840,660 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $162,034,314 | 820,510 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $144,955,667 | 845,124 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $148,747,655 | 816,846 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $129,613,187 | 836,376 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $124,323,939 | 834,053 | Shares | Defined | 2023-10-25 | |
| 2023-06-30 | $113,863,824 | 845,126 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $137,087,362 | 860,183 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $138,284,988 | 855,671 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $115,523,000 | 860,763 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $128,692,994 | 840,252 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $135,065,997 | 833,175 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $114,588,613 | 846,297 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $90,057,424 | 834,870 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $88,216,830 | 783,175 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $83,843,551 | 774,751 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $83,693,041 | 781,083 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $67,244,330 | 767,717 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $62,911,975 | 640,782 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $47,754,442 | 626,781 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||